Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:16 PM
Ignite Modification Date:
2025-12-24 @ 12:16 PM
NCT ID:
NCT06367361
Eligibility Criteria:
Inclusion Criteria:
1. Male and female subjects eighteen years or older with positive stool microscopy and/or egg counts.
2. Subjects capable of understanding the informed consent process and providing written informed consent.
3. Willingness to give informed consent.
Exclusion Criteria:
1. Subjects reporting previous treatment for fascioliasis
2. Subjects with a stool egg count \> 300 eggs/g stool
3. Women with a positive urine pregnancy test or planning to become pregnant
4. Women that are nursing
5. Alanine aminotransferase (ALT) ≥ 3 or Aspartate aminotransferase (AST) ≥ 3 times above the upper limit of normal
6. Subjects with active cerebral cysticercosis determined by serology and imaging studies
7. Subjects with known liver disease, liver cirrhosis, or end stage renal disease
8. Subjects with known allergy or AEs to benzimidazole drugs
9. Subjects taking carbamazepine, phenobarbital, phenytoin, or other medication known to decrease the serum concentrations of benzimidazoles.
10. Women unable or unwilling to use an acceptable birth control method
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06367361
Study Brief:
Protocol Section:
NCT06367361